The burden of liver disease in Europe continues to grow. We aimed to describe the
epidemiology of liver diseases and their risk factors in European countries, identifying public …

Background At global level, there are 37 million people infected with HIV and 115 million
people with antibodies to hepatitis C virus (HCV). Little is known about the extent of HIV …

HCV infection, risk-based screening failed to identify the majority of individuals with HCV
infection due to both clinician and patient barriers.(9-12) Analysis of the 2003-2010 National …

The pace of hepatitis C virus (HCV) drug development in recent years has accelerated
dramatically. For patients to benefit from these impressive advances, practitioners need …

The Swiss HIV Cohort Study (SHCS) provides a unique research platform for clinical,
translational, epidemiological, social and basic research. The SHCS was established in …

Background WHO has set targets for hepatitis C virus (HCV) elimination by 2030. We did a
global systematic review of HCV prevalence and incidence in men who have sex with men …

These guidelines for the treatment of persons who have or are at risk for sexually transmitted
diseases (STDs) were updated by CDC after consultation with a group of professionals …

These guidelines for the treatment of persons who have or are at risk for sexually transmitted
infections (STIs) were updated by CDC after consultation with professionals knowledgeable …

The HIV-1 reservoir is the major hurdle to a cure. We here evaluate viral and host
characteristics associated with reservoir size and long-term dynamics in 1,057 individuals …

Objective: The epidemiology of the incidence of sexually transmitted hepatitis C virus (HCV)
infection in HIV-positive men who have sex with men (MSM) is only partially understood. In …